US Patent Issued to Amicus Therapeutics on Sept. 23 for "High concentration alpha-glucosidase compositions for the treatment of Pompe disease" (New Jersey Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,937, issued on Sept. 23, was assigned to Amicus Therapeutics Inc. (Philadelphia).

"High concentration alpha-glucosidase compositions for the treatment of Pompe disease" was invented by Kenneth Valenzano (East Brunswick, N.J.), John Crowley (Princeton, N.J.), Richie Khanna (Somerset, N.J.) and John Flanagan (East Windsor, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides for compositions comprising high concentrations of acid Alpha-glucosidase in combination with an active site-specific chaperone for the acid Alpha-glucosidase, and methods for treating Pompe disease in a subject in need thereof, that includes a met...